Hypergammaglobulinaemia benign monoclonal+1
RecruitingA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- Disease:Hypergammaglobulinaemia benign monoclonalPlasma cell myeloma
- Substances:DexamethasoneLinvoseltamab+4
Belgium- Participants:18–64 years · 65+ years
- Substances:Dexamethasone










